Top Dividend Stocks To Add to Your Watchlist – May 16th

Direxion Daily TSLA Bull 2X Shares, ProShares UltraPro Short QQQ, Exxon Mobil, Johnson & Johnson, AbbVie, Chevron, and Merck & Co., Inc. are the seven Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are shares of publicly traded companies that distribute a portion of their earnings to shareholders on a regular basis, typically quarterly. These payments, called dividends, provide investors with a steady income stream in addition to any gains from stock price appreciation. Income-focused investors often include dividend stocks in their portfolios for cash flow stability and potential long-term growth. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

Direxion Daily TSLA Bull 2X Shares (TSLL)

Shares of Direxion Daily TSLA Bull 2X Shares stock traded up $0.50 on Friday, reaching $15.32. The company had a trading volume of 170,084,618 shares, compared to its average volume of 94,180,639. The firm’s 50-day moving average price is $9.58 and its two-hundred day moving average price is $18.31. The firm has a market cap of $7.19 billion, a price-to-earnings ratio of 60.69 and a beta of 2.63. Direxion Daily TSLA Bull 2X Shares has a 1 year low of $6.29 and a 1 year high of $41.50.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Shares of NASDAQ:SQQQ traded down $0.22 during trading hours on Friday, hitting $23.43. 60,436,150 shares of the company’s stock traded hands, compared to its average volume of 54,305,262. The business has a fifty day moving average price of $35.57 and a 200-day moving average price of $32.47. ProShares UltraPro Short QQQ has a 1 year low of $23.30 and a 1 year high of $57.95.

Exxon Mobil (XOM)

Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.

XOM stock traded down $0.41 during trading on Friday, hitting $108.18. The company had a trading volume of 8,089,923 shares, compared to its average volume of 15,534,842. The firm has a market capitalization of $466.20 billion, a P/E ratio of 13.79, a PEG ratio of 3.02 and a beta of 0.51. The company has a 50 day simple moving average of $109.00 and a 200-day simple moving average of $110.91. Exxon Mobil has a 52-week low of $97.80 and a 52-week high of $126.34. The company has a quick ratio of 0.97, a current ratio of 1.31 and a debt-to-equity ratio of 0.14.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of NYSE JNJ traded up $1.72 during trading hours on Friday, reaching $151.33. The stock had a trading volume of 4,567,390 shares, compared to its average volume of 7,929,447. The company has a current ratio of 1.11, a quick ratio of 0.86 and a debt-to-equity ratio of 0.43. The business’s fifty day moving average price is $156.56 and its two-hundred day moving average price is $154.00. The firm has a market cap of $364.11 billion, a price-to-earnings ratio of 22.76, a P/E/G ratio of 2.56 and a beta of 0.42. Johnson & Johnson has a 52-week low of $140.68 and a 52-week high of $169.99.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Shares of ABBV traded up $1.30 during midday trading on Friday, reaching $182.98. 3,703,381 shares of the stock were exchanged, compared to its average volume of 6,226,705. The company has a current ratio of 0.66, a quick ratio of 0.55 and a debt-to-equity ratio of 17.94. The company’s 50 day moving average is $191.89 and its two-hundred day moving average is $187.11. The company has a market capitalization of $323.68 billion, a P/E ratio of 76.34, a PEG ratio of 1.62 and a beta of 0.56. AbbVie has a 52 week low of $153.58 and a 52 week high of $218.66.

Chevron (CVX)

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.

Chevron stock traded down $0.22 during midday trading on Friday, hitting $142.04. 4,634,721 shares of the company’s stock were exchanged, compared to its average volume of 8,003,504. Chevron has a 12 month low of $132.04 and a 12 month high of $168.96. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.80 and a current ratio of 1.07. The company has a market cap of $248.06 billion, a PE ratio of 14.60, a P/E/G ratio of 1.46 and a beta of 0.83. The firm has a 50-day moving average of $146.89 and a two-hundred day moving average of $151.81.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

NYSE:MRK traded up $1.29 during trading hours on Friday, reaching $76.09. The company’s stock had a trading volume of 8,141,549 shares, compared to its average volume of 12,375,817. The stock has a 50 day moving average price of $83.83 and a two-hundred day moving average price of $92.51. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.15 and a current ratio of 1.36. The company has a market capitalization of $191.06 billion, a P/E ratio of 11.30, a price-to-earnings-growth ratio of 0.77 and a beta of 0.43. Merck & Co., Inc. has a 12 month low of $73.31 and a 12 month high of $134.63.